IL-15 Superagonist ALT-803 for Treatment of Advanced Sta

Project: Research project

Project Details

Description

IL-15 Superagonist ALT-803 for Treatment of Advanced Staged Ovarian Cancer
StatusActive
Effective start/end date7/17/177/31/20

Funding

  • MN OVARIAN CANCER ALLIANCE

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.